Development of Platinum Complexes for Tumor Chemoimmunotherapy

SX Jin and Y Guo and XY Wang, CHEMISTRY-A EUROPEAN JOURNAL, 30, e202302948 (2024).

DOI: 10.1002/chem.202302948

Platinum complexes are potential antitumor drugs in chemotherapy. Their impact on tumor treatment could be greatly strengthened by combining with immunotherapy. Increasing evidences indicate that the antitumor activity of platinum complexes is not limited to chemical killing effects, but also extends to immunomodulatory actions. This review introduced the general concept of chemoimmunotherapy and summarized the progress of platinum complexes as chemoimmunotherapeutic agents in recent years. Platinum complexes could be developed into inducers of immunogenic cell death, blockers of immune checkpoint, regulators of immune signaling pathway, and modulators of tumor immune microenvironment, etc. The synergy between chemotherapeutic and immunomodulatory effects reinforces the antitumor activity of platinum complexes, and helps them circumvent the drug resistance and systemic toxicity. The exploration of platinum complexes for chemoimmunotherapy may create new opportunities to revive the discovery of metal anticancer drugs. Chemoimmunotherapy is a novel treatment for cancers via synergy between chemotherapy and immunotherapy. Pt complexes could be developed into chemoimmunotherapeutic agents as inducers of immunogenic cell death, inhibitors of immune checkpoint, stimulators of immune response, relievers of immunosupression, or modulators of immune signal. They reshape the tumor microenvironment and reinforce the antitumor activity.image

Return to Publications page